Cumberland Pharmaceuticals (CPIX) Enterprise Value (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Enterprise Value of -$11.3 million for Q1 2026, up 3.74% sequentially from -$11.8 million in Q4 2025, and up 26.48% YoY from -$9.0 million in Q1 2025.
Cumberland Pharmaceuticals (CPIX) Enterprise Value (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Enterprise Value for 17 years, with the latest figure at -$11.3 million in Q1 2026.
- Quarterly Enterprise Value rose 26.48% year-over-year to -$11.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$11.3 million (up 26.48% YoY) and the FY2025 annual result came in at -$11.8 million, up 35.52% from the prior year.
- Enterprise Value advanced to -$11.3 million in Q1 2026 per CPIX's latest filing, from -$11.8 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$11.3 million in Q1 2026 and troughed at -$20.1 million in Q4 2022.
- A 5-year average of -$17.2 million and a median of -$17.8 million in 2024 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value decreased 12.88% in 2024, then surged 35.52% in 2025.
- Over 5 years, Enterprise Value stood at -$20.1 million in 2022, then advanced by 6.91% to -$18.7 million in 2023, then increased by 2.11% to -$18.3 million in 2024, then soared by 35.52% to -$11.8 million in 2025, then advanced by 3.74% to -$11.3 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$11.3 million, -$11.8 million, and -$15.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | -164.00 Mn |
| 10 | Cumberland Pharmaceuticals | 117.68 Mn | 113.82 Mn | - | -4.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.19 Mn |
| Mar 31, 2026 | -11.34 Mn |
| Dec 31, 2025 | -11.78 Mn |
| Sep 30, 2025 | -15.52 Mn |
| Jun 30, 2025 | -16.40 Mn |
| Mar 31, 2025 | -15.42 Mn |
| Dec 31, 2024 | -18.27 Mn |
| Sep 30, 2024 | -17.77 Mn |
| Jun 30, 2024 | -17.65 Mn |
| Mar 31, 2024 | -18.85 Mn |
| Dec 31, 2023 | -18.67 Mn |
| Sep 30, 2023 | -18.84 Mn |
| Jun 30, 2023 | -18.57 Mn |
| Mar 31, 2023 | -16.70 Mn |
| Dec 31, 2022 | -20.05 Mn |
| Sep 30, 2022 | -19.81 Mn |
| Jun 30, 2022 | -18.48 Mn |
| Mar 31, 2022 | -17.50 Mn |
| Dec 31, 2021 | -27.25 Mn |
| Sep 30, 2021 | -26.02 Mn |